For selected genes, such as RPE65, gene augmentation using viral vectors is a therapeutic possibility, and gene augmentation using adeno-associated viruses (AAVs) represent the most promising approach for preventing photoreceptor cell degeneration in IRDs [44]. The gene discussed is RPE65; the disease is respiratory distress syndrome in premature infants.